The last presentation was July 10, 2013. The last TRX shown is 1141, I had projected 1129, close for Q2. Projecting out using the same formula I now project 1520 per week for Q3, very well done Delia. This doesn't mean we are right, although I believe we will be proven correct. Of course what this translates into is exactly what you show $$$$$$$$. Also consider that Santarus increased prices for its Glumetza and Zegerid drugs June 2013, therefore they should reach the high end of their revenue estimates or surpass those estimates. I hope to know the actual numbers when Santarus presents in NY and Boston September 10 and 11. Q3 looks like $100M plus IMO.